197 related articles for article (PubMed ID: 34830047)
1. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia.
Fei F; Zhang M; Tarighat SS; Joo EJ; Yang L; Heisterkamp N
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430839
[TBL] [Abstract][Full Text] [Related]
3. Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008.
Paz H; Joo EJ; Chou CH; Fei F; Mayo KH; Abdel-Azim H; Ghazarian H; Groffen J; Heisterkamp N
J Exp Clin Cancer Res; 2018 Mar; 37(1):67. PubMed ID: 29580262
[TBL] [Abstract][Full Text] [Related]
4. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3.
Fei F; Joo EJ; Tarighat SS; Schiffer I; Paz H; Fabbri M; Abdel-Azim H; Groffen J; Heisterkamp N
Oncotarget; 2015 May; 6(13):11378-94. PubMed ID: 25869099
[TBL] [Abstract][Full Text] [Related]
5. Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia.
Bum-Erdene K; Collins PM; Hugo MW; Tarighat SS; Fei F; Kishor C; Leffler H; Nilsson UJ; Groffen J; Grice ID; Heisterkamp N; Blanchard H
J Med Chem; 2022 Apr; 65(8):5975-5989. PubMed ID: 35427125
[TBL] [Abstract][Full Text] [Related]
6. Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells.
Kihira K; Chelakkot VS; Kainuma H; Okumura Y; Tsuboya N; Okamura S; Kurihara K; Iwamoto S; Komada Y; Hori H
Int J Hematol; 2020 Dec; 112(6):795-806. PubMed ID: 32862292
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
[TBL] [Abstract][Full Text] [Related]
8. Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence.
Luong A; Cerignoli F; Abassi Y; Heisterkamp N; Abdel-Azim H
PLoS One; 2021; 16(9):e0258140. PubMed ID: 34591931
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.
Buske C; Becker D; Feuring-Buske M; Hannig H; Wulf G; Schäfer C; Hiddemann W; Wörmann B
Leukemia; 1997 Mar; 11(3):386-92. PubMed ID: 9067578
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion.
Yu K; Wang J; Lu T; Ma D; Wei D; Guo Y; Cheng B; Wang W; Fang Q
J Cell Biochem; 2019 Oct; 120(10):17791-17810. PubMed ID: 31264739
[TBL] [Abstract][Full Text] [Related]
11. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.
Stamatopoulos B; Meuleman N; De Bruyn C; Pieters K; Mineur P; Le Roy C; Saint-Georges S; Varin-Blank N; Cymbalista F; Bron D; Lagneaux L
Haematologica; 2012 Apr; 97(4):608-15. PubMed ID: 22058221
[TBL] [Abstract][Full Text] [Related]
12. B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment.
Polak R; de Rooij B; Pieters R; den Boer ML
Blood; 2015 Nov; 126(21):2404-14. PubMed ID: 26297738
[TBL] [Abstract][Full Text] [Related]
13. Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4.
Yu K; Yin Y; Ma D; Lu T; Wei D; Xiong J; Zhou Z; Zhang T; Zhang S; Fang Q; Wang J
Int Immunopharmacol; 2020 Mar; 80():106008. PubMed ID: 31978797
[TBL] [Abstract][Full Text] [Related]
14. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients.
Traxel S; Schadt L; Eyer T; Mordasini V; Gysin C; Munthe LA; Niggli F; Nadal D; Bürgler S
Oncogene; 2019 Mar; 38(13):2420-2431. PubMed ID: 30532071
[TBL] [Abstract][Full Text] [Related]
16. Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.
Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500796
[TBL] [Abstract][Full Text] [Related]
17. Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy.
Pramanik R; Sheng X; Ichihara B; Heisterkamp N; Mittelman SD
Leuk Res; 2013 May; 37(5):503-9. PubMed ID: 23332453
[TBL] [Abstract][Full Text] [Related]
18. Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.
Huang M; Inukai T; Miyake K; Tanaka Y; Kagami K; Abe M; Goto H; Minegishi M; Iwamoto S; Sugihara E; Watanabe A; Somazu S; Shinohara T; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2018 Apr; 7(4):1297-1316. PubMed ID: 29473342
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.
Pan C; Liu P; Ma D; Zhang S; Ni M; Fang Q; Wang J
Biomed Pharmacother; 2020 Oct; 130():110610. PubMed ID: 34321159
[TBL] [Abstract][Full Text] [Related]
20. Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.
Abedi M; Rahgozar S; Esmaeili A
Cancer Med; 2020 May; 9(10):3537-3550. PubMed ID: 32176452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
